Understanding Neutrophil to Lymphocyte Ratio: The Most Important and Overlooked Biomarker of Systemic Inflammation in Cancer: Part 1

Inflammation is an essential part of our body’s immune defense. When we encounter pathogens such as bacteria, viruses, or parasites, our body responds with inflammation to fight the invaders and increase immune response. In these instances, inflammation is beneficial. But inflammation has a dark side—left unchecked, it can wreak havoc on cells, tissues, and organs. For example, it’s well established that chronic inflammation is a powerful force in the initiation, growth, and spread of cancer.

There are three essential points to consider: First, a chronic inflammatory state can, over time, initiate cancer development. Second, we still need to find the cause of the chronic state of inflammation—for example, pathogenic (chronic infection), life-style, stress, years of poor eating, or a combination of the above. And third, it is important to keep in mind that the cancer energy, as it gains in intelligence, manipulates our immune system, creating a cancer-favorable, pro-inflammatory micro-environment.

Research indicates that the systemic manifestations of inflammation can provide a valuable biomarker for prognosis and treatment stratification. Numerous studies indicate that a simple indicator of systemic inflammation—based on neutrophilia and/or lymphocytopenia—can provide prognostic information in a wide range of cancer types. In particular, the value of one index (the dNLR) derived from total white cell and neutrophil counts, is enabling large retrospective studies to be carried out.

Although not informative from a biological standpoint in distinguishing cause from effect, the results of these studies are likely to be of significance in how we approach cancer. In my practice, I always consider the role of inflammation in cancer and tailor protocols for patients accordingly. The following markers are among those I consider most important:

  • Tumor-associated neutrophils (TANs)
    Bio-Markers: CD11b+, CD66b+, CD63+

Tumor-associated neutrophils (TAN) play a major role in cancer biology. Neutrophils are the most abundant circulating leukocyte in humans, and are phenotypically plastic. Neutrophils, as a key component in inflammation, often play a crucial role in inflammation driven tumorigenesis. TAN can take an anti-tumorigenic (what we are calling an “N1-phenotype”) versus a pro-tumorigenic (“N2”) phenotype. The anti-tumor activities of N1 TANs include expression of more immuno-activating cytokines and chemokines, lower levels of arginase, and more capability of killing tumor cells. N2 neutrophils are pro-tumorigenic, and secrete T2 cytokines.

Continue reading “Understanding Neutrophil to Lymphocyte Ratio: The Most Important and Overlooked Biomarker of Systemic Inflammation in Cancer: Part 1”

Current Research into Botanicals and Cancer

As a follow-up to my post last week, Botanical Medicine: A Symphony in Harmony Against Cancer, I want to present some of the latest research into botanicals and cancer.

Researchers are investigating the potential of botanicals to treat all types of cancers, studying the use of natural compounds to prevent or reverse the process of carcinogenesis. For example, head and neck squamous cell carcinoma (HNSCC) is one of the most fatal cancers. Despite advances in the management of HNSCC, the overall survival for patients has not improved significantly due to advanced stages at diagnosis, high recurrence rate after surgical removal, and second primary tumor development. To develop approaches that can intervene at any stage of cancer development requires understanding of the crosstalk between cancer signaling pathways and networks to retain or enhance chemopreventive activity while reducing known toxic effects. Researchers are discovering that many natural dietary compounds have been identified as multiple molecular targets, effective in the prevention and treatment of cancer.1

Continue reading “Current Research into Botanicals and Cancer”

Botanical Medicine: How Herbs Represent A Symphony in Harmony Against Cancer

The world of Western conventional medicine is oriented to the ‘magic bullet’ paradigm, where the search for drugs relies on the concept of compounds that bind specifically to a single target and demonstrate a high degree of potency. Recently, though, this approach has broadened, with researchers suggesting that it is non-specific and relatively weak patterns of activity that may ultimately prove of greatest importance in drug discovery. Though research on multi-targeted drugs is still at an early stage, studies indicate that certain antipsychotic drugs, for instance, appear to be more effective when several types of receptors are targeted.1-3

Traditional herbal medicine recognized centuries ago that combining many plants delivers far better results than relying on a single plant. This is true both for supporting health and vitality and for treating imbalances and diseases. The multi-component nature inherent in medicinal herbs makes them particularly suitable for managing the multitude of issues that present in complex diseases such as cancer, and offers great potential for synergistic actions, including interactions between botanicals and the relationship of botanicals to conventional cytotoxic drugs such as chemotherapy and targeted agents.

Continue reading “Botanical Medicine: How Herbs Represent A Symphony in Harmony Against Cancer”

Do Antioxidants Prevent or Accelerate Cancer?

In a recent article published in Medscape, the authors state that antioxidants are not only useless in preventing cancer, but quite possibly promote cancer growth. The target audience for this article is primary care clinicians, oncologists, nurses, and other clinicians who care for patients at risk for cancer, with the purported goal of providing “medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.”

I find this article disturbing, to say the least. Here’s why:

1) The article is blatantly biased. The authors point out only the few studies that have concluded negative results, while totally ignoring all of the positive studies—of which there are several hundred, or more. I do not understand how in good conscience they can skew the research findings in this way. Furthermore, I’m not certain of what they have to gain from this inaccurate representation of the total body of research available.

2) Their theory of antioxidants in relationship to cancer is completely wrong. The studies they use for their findings involve mostly synthetic forms of vitamin or mineral isolates. This is far removed from nature, and something I would never recommend. It’s essential to understand that the negative impact and possible increase in cancer incidence is related to a substance being a ‘PRO-OXIDANT’ and not an anti-oxidant. For example, high doses of vitamin C, K-3, beta-carotene, and E are all pro-oxidative when used as isolates, in high doses, and in certain conditions. It’s well established that smokers who take synthetic beta-carotene have an increased incidence of lung cancer. This does not mean that antioxidants cause cancer.

3) Details matter! It raises my ire when people use the word antioxidant in a general way. What specifically are they talking about? For example, the researchers for this article refer to the SELECT trial. Let’s explore this in a bit more depth to understand what the trial really reveals about antioxidants.

Continue reading “Do Antioxidants Prevent or Accelerate Cancer?”

Cancer: Why Quick Fix Solutions Fall Short—and Why ETMS Succeeds

As I observe the ways the ways of modern life, it’s obvious to me that we are living in a “quick-fix” world. Technology has lured us into a lifestyle of instant gratification—and we have come to expect swift solutions to every problem that arises. In daily life, the expectation of immediate gratification frequently leads to disappointment and frustration. For those facing cancer or other chronic disease, the quest for a quick fix is often devastating.

I regularly see in the press the promise of a simple solution for cancer or other chronic disease. The Internet is especially problematic because it spreads vast amounts of misinformation, which unfortunately, many people believe is factual. As a long-time practitioner who has worked with hundreds of people with life-threatening illnesses (I have dedicated my life to helping those with cancer) I can tell you that there is no quick fix. I wish there were. Illness makes people vulnerable, and regrettably, there are those who would lead you to believe that a simple solution exists for cancer or other serious illness. The truth is that the initiation and progression of cancer involves a variety of complex contributing factors. These factors involve not only the cancer, but also the individual who is the host for the cancer. It’s unrealistic to think that any one “magic bullet,” whether conventional or alternative in nature, can eradicate cancer or any other significant illness.

Continue reading “Cancer: Why Quick Fix Solutions Fall Short—and Why ETMS Succeeds”

Integrating Botanical Medicine in Cancer Therapies

As an herbalist with 25 years of clinical experience, I witness on a daily basis the remarkable healing properties of plants. Although the foundation of my healing approach is deeply rooted in traditional medical philosophies and practices, I draw extensively upon modern scientific research as a vital cornerstone for my work.

The majority of my patients have been diagnosed with cancer, and many turn to me after they have exhausted all that modern medicine has to offer. Merging traditional nature-based medical systems with modern, scientifically based conventional medical knowledge enables me to significantly help the difficult cases I so often encounter. I have an inner drive to do anything and everything I can for each person I work with to utilize all lens and tools of the various toolboxes, finding the pieces that fit together to promote and sustain healing. It is a true integration of the mind and heart, thinking and praying together. Researching and reviewing the latest scientific studies is part of my daily routine, and this continual stream of research contributes to the rationale for my clinical recommendations.

Continue reading “Integrating Botanical Medicine in Cancer Therapies”